BBNI:IDXPT Bank Negara Indonesia (Persero) Tbk Class B Analysis
Data as of 2026-03-14 - not real-time
IDR 4,240.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
PT Bank Negara Indonesia (Persero) Tbk trades at a **price‑earnings multiple of 7.9**, well below the industry average of 16.3, and its price‑to‑book ratio sits under 1, indicating a clear *undervaluation* opportunity. The stock also offers an **8.24% dividend yield** with a payout ratio of roughly 70%, although the sustainability of this payout is questionable given the negative operating cash flow. Analyst consensus is strongly positive ("strong_buy") with a median target of 5,200 IDR, implying an upside of about 18% from the current 4,240 IDR price.
Technically, the share is below its 20‑day (4,368), 50‑day (4,409) and 200‑day (4,295) SMAs, the RSI sits at 39 indicating modest oversold pressure, and the MACD histogram is negative, signaling short‑term bearish momentum. However, volume is increasing, support sits at 4,120 IDR and the broader market sentiment is in a "Greed" phase (Fear‑Greed Index 72.9), suggesting a potential bounce if buying pressure resumes.
Technically, the share is below its 20‑day (4,368), 50‑day (4,409) and 200‑day (4,295) SMAs, the RSI sits at 39 indicating modest oversold pressure, and the MACD histogram is negative, signaling short‑term bearish momentum. However, volume is increasing, support sits at 4,120 IDR and the broader market sentiment is in a "Greed" phase (Fear‑Greed Index 72.9), suggesting a potential bounce if buying pressure resumes.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below short‑term SMAs indicates bearish bias
- RSI near oversold level may limit downside
- High dividend yield but cash‑flow strain
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation discount vs peers
- Analyst consensus strong_buy with 18% upside
- Revenue and EPS growth despite modest top‑line expansion
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Stable banking sector and strong market position
- Attractive dividend yield for income investors
- Long‑term upside potential from undervaluation and earnings expansion
Key Metrics & Analysis
Financial Health
Revenue Growth2.80%
Profit Margin40.23%
P/E Ratio7.9
ROE11.73%
ROA1.61%
P/B Ratio0.9
Op. Cash FlowIDR-125235500154880
Industry P/E16.4
Technical Analysis
TrendNeutral
RSI39.1
SupportIDR 4,120.00
ResistanceIDR 4,550.00
MA 20IDR 4,368.50
MA 50IDR 4,409.20
MA 200IDR 4,295.20
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Target PriceIDR 5,029.14
Upside/Downside18.61%
GradeUndervalued
TypeValue
Dividend Yield8.24%
Risk Assessment
Beta0.34
Volatility20.17%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.